DMG — Dr Miele Cosmed SA Income Statement
0.000.00%
- PLN344.99m
- PLN399.58m
- PLN488.35m
- 92
- 73
- 14
- 66
Annual income statement for Dr Miele Cosmed SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 365 | 352 | 397 | 444 | 488 |
Cost of Revenue | |||||
Gross Profit | 160 | 133 | 125 | 172 | 208 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 333 | 337 | 395 | 411 | 440 |
Operating Profit | 31.9 | 15.1 | 1.31 | 33 | 48.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 31.3 | 13.3 | -2.1 | 27.2 | 43.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.6 | 11.6 | -2.27 | 22.2 | 36 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.6 | 11.6 | -2.27 | 22.2 | 36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.6 | 11.6 | -2.27 | 22.2 | 36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.306 | 0.135 | -0.018 | 0.253 | 0.4 |
Dividends per Share |